143 related articles for article (PubMed ID: 38380160)
1. Preference for long-acting injectable for ART and PrEP among people with and without HIV: a cross-sectional study in Argentina.
Sciannameo S; Zalazar V; Spadaccini L; Duarte M; Cahn P; Aristegui I; Sued O
Ther Adv Infect Dis; 2024; 11():20499361241228341. PubMed ID: 38380160
[TBL] [Abstract][Full Text] [Related]
2. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
Schoenberg P; Edwards OW; Merrill L; Martinez CA; Stephenson R; Sullivan PS; Jones J
J Int AIDS Soc; 2023 Mar; 26(3):e26077. PubMed ID: 36951057
[TBL] [Abstract][Full Text] [Related]
3. Preferences for long-acting pre-exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey.
Hsu JH; Ku SW; Chen TW; Li CW; Huang P; Wu HJ; Bourne A; Strong C
J Int AIDS Soc; 2023 Sep; 26(9):e26163. PubMed ID: 37675767
[TBL] [Abstract][Full Text] [Related]
4. Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.
Parsons JT; Rendina HJ; Whitfield TH; Grov C
AIDS Behav; 2016 Jul; 20(7):1390-9. PubMed ID: 27000145
[TBL] [Abstract][Full Text] [Related]
5. Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among Young Adult Sexual Minority Men and Transgender Women.
Weeden T; Garofalo R; Johnson AK; Schnall R; Cervantes M; Scherr T; Kuhns LM
Acad Pediatr; 2024 Apr; ():. PubMed ID: 38631476
[TBL] [Abstract][Full Text] [Related]
6. Patient and Physician Preferences Regarding Long-Acting Pre-Exposure Prophylaxis and Antiretroviral Therapy: A Mixed-Methods Study in Southern California, USA.
Yeager S; Montoya JL; Burke L; Chow K; Moore DJ; Morris S
AIDS Res Hum Retroviruses; 2022 Nov; 38(11):856-862. PubMed ID: 35972754
[TBL] [Abstract][Full Text] [Related]
7. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
Cheng CY; Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Terris-Prestholt F
BMC Public Health; 2019 Jul; 19(1):996. PubMed ID: 31340785
[TBL] [Abstract][Full Text] [Related]
8. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.
Shrestha R; DiDomizio EE; Kim RS; Altice FL; Wickersham JA; Copenhaver MM
J Subst Abuse Treat; 2020 Oct; 117():108058. PubMed ID: 32811633
[TBL] [Abstract][Full Text] [Related]
9. Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey.
Fu J; Dai Z; Wang H; Si M; Chen X; Wu Y; Xiao W; Huang Y; Yu F; Mi G; Su X
PLoS One; 2023; 18(10):e0293297. PubMed ID: 37856527
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition.
Lorenzetti L; Dinh N; van der Straten A; Fonner V; Ridgeway K; Rodolph M; Schaefer R; Schmidt HA; Baggaley R
J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26107. PubMed ID: 37439057
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men.
Dean LT; Predmore Z; Skinner A; Napoleon S; Chan PA; Raifman J
AIDS Behav; 2023 Aug; 27(8):2606-2616. PubMed ID: 36670210
[TBL] [Abstract][Full Text] [Related]
12. Preferences for PrEP modalities among gay, bisexual, and other men who have sex with men from Brazil, Mexico, and Peru: a cross-sectional study.
Torres TS; Nascimento AR; Coelho LE; Konda KA; Vega-Ramirez EH; Elorreaga OA; Diaz-Sosa D; Hoagland B; Guanira JV; Pimenta C; Benedetti M; Caceres CF; Veloso VG; Grinsztejn B
Ther Adv Infect Dis; 2023; 10():20499361231153548. PubMed ID: 36814515
[TBL] [Abstract][Full Text] [Related]
13. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
[TBL] [Abstract][Full Text] [Related]
14. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
[TBL] [Abstract][Full Text] [Related]
15. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.
Mansergh G; Kota KK; Stephenson R; Hirshfield S; Sullivan P
J Int AIDS Soc; 2021 Jan; 24(1):e25664. PubMed ID: 33481359
[TBL] [Abstract][Full Text] [Related]
16. Perceived Barriers to and Facilitators of Long-Acting Injectable HIV PrEP Use Among Black, Hispanic/Latino, and White Gay, Bisexual, and Other Men Who Have Sex With Men.
Tran NK; Martinez O; Scheim AI; Goldstein ND; Welles SL
AIDS Educ Prev; 2022 Oct; 34(5):365-378. PubMed ID: 36181495
[TBL] [Abstract][Full Text] [Related]
17. Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
John SA; Whitfield THF; Rendina HJ; Parsons JT; Grov C
AIDS Behav; 2018 Apr; 22(4):1184-1189. PubMed ID: 28913659
[TBL] [Abstract][Full Text] [Related]
18. Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia.
Chan C; Vaccher S; Fraser D; Grulich AE; Holt M; Zablotska-Manos I; Prestage GP; Bavinton BR
AIDS Behav; 2022 Jan; 26(1):88-95. PubMed ID: 34142274
[TBL] [Abstract][Full Text] [Related]
19. Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S.
Irie WC; Calabrese SK; Patel RR; Mayer KH; Geng EH; Marcus JL
AIDS Behav; 2022 Jul; 26(7):2212-2223. PubMed ID: 34985607
[TBL] [Abstract][Full Text] [Related]
20. Intention and preference to use long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approach.
Wang H; Zimmermann HML; van de Vijver D; Jonas KJ
AIDS Care; 2024 May; ():1-12. PubMed ID: 38713631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
